Lycopeensupplementen verlagen niet prostaatkanker

Research Question:
Lycopeensupplementen swallowing lowers the chances of getting prostate cancer?

Study Design:
This overview article contained 8 Rcts. There was talk of bias.

Results and conclusions:
The researchers found in a meta-analysis of 4 Rcts that swallowing lycopeensupplementen the chance of getting benign prostatic hyperplasia (a benign enlargement of the prostate) not significant with 5% [95% CI = 0.63-1.44] reduced.
Not significant is, there is no link to a 95% reliability.

The researchers found in a meta-analysis of 4 Rcts that swallowing lycopeensupplementen the chance of getting prostate cancer by 8% not significant [RR = 0.92, 95% CI = 0.66-1.29] reduced.
Not significant is, there is no link to a 95% reliability.

The researchers found in a meta-analysis of 2 Rcts that swallowing of lycopeensupplementen the value of PSA-prostate cancer patients significantly with 1.58 [95% CI =-2.61 to-0.55] reduced.
Significant is, there is a link at a 95% reliability.

The researchers concluded that it is not yet scientifically proven was to lycopeensupplementen for write for prevention or treatment of prostate cancer.

Original title:
Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: A systematic review by Ilic D and Valerie M.

Link:
http://www.maturitas.org/article/S0378-5122%2812%2900160-0/abstract

Additional information about El Mondo:
Read more about lycopeenstudies.

Prostate cancer is rare in men younger than 40 years.

The Prostate specific antigen (PSA) is a protein that is normally present in the blood to a small degree. It is formed in the glandular tissue of the prostate, both in a healthy as in a diseased prostate.
In benign prostatic hyperplasia (BPH) and prostate cancer, the PSA level increased.

Age (years)

Reference value of PSA

40-49

2.5

50-59

3.5

60-69

4.5

70-79

6.5